Expression of matrix metalloproteinase-9 in thrombin-induced brain edema formation in rats

Kenya Kawakita1, Nobuyuki Kawai, Yasuhiro Kuroda

  • 1Department of Neurological Surgery, Kagawa University School of Medicine, Kagawa, Japan.

Insights

Thrombin injection in rats causes brain edema by increasing matrix metalloproteinase-9 (MMP-9) expression. Inhibiting thrombin or MMP-9 reduces this edema, suggesting potential treatments for intracerebral hemorrhage.

Area of Science:

  • Neuroscience
  • Biochemistry

Background:

  • Thrombin contributes to brain edema after intracerebral hemorrhage by disrupting the blood-brain barrier.
  • Matrix metalloproteinases (MMPs), particularly MMP-9, are implicated in blood-brain barrier disruption.

Purpose of the Study:

  • To investigate if thrombin injection into the brain parenchyma induces MMP-9 expression in rats.
  • To explore the role of MMP-9 in thrombin-induced brain edema.

Main Methods:

  • Rats received intraparenchymal thrombin injections.
  • Brain water content, MMP-9 mRNA, and protein expression were measured at various time points.
  • The effects of thrombin inhibitor (hirudin) and MMP inhibitor (GM6001) were assessed.

Main Results:

  • Thrombin injection significantly increased brain water content and MMP-9 expression (mRNA and protein).
  • Hirudin co-administration nearly abolished edema and MMP-9 expression.
  • GM6001 administration markedly reduced brain edema.

Conclusions:

  • Intraparenchymal thrombin induces brain edema formation via MMP-9 up-regulation in rats.
  • Inhibiting MMP activity presents a potential therapeutic strategy for reducing edema post-intracerebral hemorrhage.